Gladstone C McDowell II MD
Pain Medicine
President - Targeted Care Solutions Founder/Medical Director- Integrated Pain Solutions Founder/Medical Director-Gemini Surgery Center Former CMO- Midwest American Pain Consortium
Join to View Full Profile
1210 Gemini PlaceSuite 300Columbus, OH 43240
Phone+1 614-383-6450
Fax+1 614-383-6455
Dr. McDowell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gladstone McDowell II, based in Columbus, OH, specializes in Anesthesiology with a subspecialty in Pain Medicine. He completed his anesthesiology residency at the University of Colorado and Ohio State University Hospital, and also had prior training in Urology. He currently serves as CEO/President at Targeted Care Solutions and was previously Director of Pain Management at Ohio Health Hospital System and founder of Integrated Pain Solutions and Gemini Surgery Center. His expertise includes complex regional pain syndrome, chronic pain, cancer pain, clinical research, and musculoskeletal ultrasonography. Dr. McDowell has contributed several publications in his field and led clinical trials such as the Patient Registry of Intrathecal Ziconotide Management. He has been recognized with certifications for CMS Meaningful Use Stages 1 and 2 and was named a Top MD by Consumers Checkbook.
Education & Training
Ohio State University HospitalResidency, Anesthesiology, 1997 - 1998
University of ColoradoResidency, Anesthesiology, 1994 - 1997
University of Texas Health Science Center at HoustonResidency, Urology, 1987 - 1989- Ohio State University HospitalResidency, Urology, 1982 - 1986
The University of Texas Health Science Center at San AntonioClass of 1982
Certifications & Licensure
OH State Medical License 1983 - 2026
TX State Medical License 1983 - 2000
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification IMS, MedPharm Services LLC, 2015-2017
- CMS Meaningful Use Stage 2 Certification IMS, MedPharm Services LLC, 2015-2017
- Top MD Consumers Checkbook
Clinical Trials
- Implantable Systems Performance Registry Start of enrollment: 2003 Aug 01
- Patient Registry of Intrathecal Ziconotide Management(PRIZM) Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 3 citationsA post-market, randomized, controlled, prospective study evaluating intrathecal pain medication versus conventional medical management in the non-cancer, refractory, c...Jason E Pope, Navdeep Jassal, Dawood Sayed, Denis Patterson, Gladstone McDowell
Expert Review of Medical Devices. 2022-11-01 - 6 citationsEffectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM).Gladstone C. McDowell, Michael Saulino, Mark S. Wallace, Eric Grigsby, Richard Rauck
Pain Medicine. 2020-11-01 - 10 citationsPhysician Guidance on the Use of Off-Labeled Drugs in Intrathecal Drug Delivery Systems for Chronic Pain.Timothy R. Deer, Phillip Kim, Jason E. Pope, Salim M. Hayek, Gladstone C. McDowell
Neuromodulation. 2019-10-01
Committees
- Member, Neuromodulation Consensus Committee 2013 - 2017
- Member, Polyanalgesic Consensus Committee 2007 - 2024
Professional Memberships
- American Society of Regional AnesthesiaMember
- North American Neuromodulation SocietyMember
Industry Relationships
- Research, MallinckrodtCNS-HYD 201 and 202 intrathecal study2013 - 2015
- Consultant/Research, Flowonix2012 - 2015
- Consultant/Research/Speaker, Jazz Pharma2012 - 2015
- Consultant/Research/Speaker, Medtronic2005 - 2015
External Links
- Integrated Pain Solutionshttp://ipscolumbus.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
